GlassScriptPhysician profile
Clayton Dean
NPI 1144431180
$9,416.29
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.81 · 2020: $12.93 · 2021: $953 · 2022: $8,356.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $9,251.11 | 2021-2022 | |
| Kuros Biosciences USA, INC | $58.44 | 2021 | |
| Si-Bone, INC. | $36.19 | 2019 | |
| Spineology INC. | $24.07 | 2019-2020 | |
| Abbott Laboratories | $20.00 | 2019 | |
| Smith+Nephew, INC. | $14.82 | 2019 | |
| Providence Medical Technology, INC. | $11.66 | 2019 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$923,366.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clayton Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.